Theravance, Astellas get European nod for Vibativ; Abbott lays off 160 in diagnostics restructuring;

@FiercePharma: FDA expects another foreign-drug safety crisis a la heparin ... if it doesn't get more enforcement powers. Story | Follow @FiercePharma

> European regulators approved Theravance and Astellas Pharma's antibiotic Vibativ to treat pneumonia suspected to be caused by MRSA. Release

> Abbott Laboratories ($ABT) has laid off 160 employees as part of ongoing restructuring within its diagnostics division. News

> Eli Lilly ($LLY) India's CEO says the company will rely on its own original drugs to grow on the subcontinent, rather than buying in "a slew of branded generics." Report

> Eli Lilly is expanding its social media efforts with a YouTube channel and a new Facebook page. Item

> Novartis ($NVS) study finds Galvus safe and effective in diabetics with severely impaired kidney function. Story

> Spencer Pharmaceutical officials said Al-Dorra/Hail First Pharma's buyout offer should be rejected; the bid has not been changed since June. Spencer release

> Women who can buy longer-term supplies of birth-control pills are more likely to stick with them. Article

Biotech News

@FierceBiotech: FDA approves test to determine chances of ovarian cancer. Piece | Follow @FierceBiotech

@JohnCFierce: Soligenix will now look at cost containment measures now that orBec Ph3 is a bust. Here's the PR: Item | Follow @JohnCFierce

@RyanMFierce: Neat. Computer-based therapy for anxiety may be as effective as seeing a therapist or taking drugs. Brown U.'s release: Release | Follow @RyanMFierce

@MaureenFierce:  Bionor HIV vaccine lowers viral load, ART need. Report | Follow @MaureenFierce

> Soligenix slams the door on disappointing orBec Ph3. Item 

Vaccines News

> FDA lifts clinical hold on RXi's breast cancer vaccine. News

> Bionor HIV vaccine lowers viral load, ART need. Story 

> Researchers find weakness in hep C virus. Report

> Medicago unveils new NC manufacturing plant. Article 

> Study: For HPV, two shots may be enough. News

Manufacturing News

> Daiichi riding GMP rollercoaster with FDA. Report

> Teva gets close-out letter over Jerusalem plant. Story 

> Competition forcing marriage of iPads, ops data for execs. Article

> Seattle the exception in hosting medical marijuana dispensaries. Report 

> Catalent expansions show close pharma-biz tracking. News  

And Finally... Harvard releases its own version of the government's "healthy plate" eating advice. Report

Suggested Articles

California CDMO JSR Life Sciences is building a new home for two subsidiaries as it hopes to enter the competitive biologics market.

Three facts about how distributors are managing in-demand inventory.

Novartis’ latest campaign with a celebrity dance partner asks people to bust a move to raise awareness around sickle cell anemia and therapy Adakveo.